(1)
KABAN, S. M.; Siti Syarifah; Pane, Y. S.; Tri Widyawati. The Relationship Between SLC22A16 Gene Polymorphism and Hematological Toxicity in Breast Cancer Patients Receiving Doxorubicin-Based Chemotherapy. JETROMI 2025, 7, 27-33.